Anti-BTLA/CD272 Antibody (Icatolimab)
Catalog No.
F1307
Anti-BTLA/CD272 Antibody (Icatolimab)
Featured Products
Icatolimab is a CHO-expressed humanized antibody targeting BTLA/CD272. Icatolimab has a huIgG4SP-type heavy chain and a huκ-type light chain with a predicted molecular weight (MW) of 146 kDa.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
146 kDa
Dry ice
2236068-83-8
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
JS004, TAB004
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q7Z6A9
Human
Unconjugated
Monoclonal
Protein A
IgG4SP
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human BTLA His at 2 ug/mL can bind Anti-BTLA/CD272 Antibody (Icatolimab)
BTLA / CD272
Please avoid freeze-thaw cycles.